Recent advances in genetic testing technology have transformed personal health care from general guidelines to precise, ...

If the patient carry two variants in the gene (a complete absence of DPD), other drugs are recommended instead if possible, or a quarter of the usual starting dose is used. · Genetic testing is ...

EXTON, PA / ACCESSWIRE / November 12, 2024 / Frontage Laboratories, Inc ., a global CRO, and Medicover Integrated Clinical ...

A new study led by Genomics England and Queen Mary University of London estimates that genetic testing could identify approximately 14,540 patients per year on any of 5 commonly prescribed drugs who ...

Scientists pinpointed 80 gene variants, including eight tied to fatty acid metabolism, that may cause breast cancer in some ...

The NMR and Drug Metabolism Core at Baylor College of Medicine offers tools to support the discovery, synthesis, screening, optimization, metabolism and pharmacokinetics of small molecule ligands or ...

Alongside its genetic testing service, 23andMe is also expanding the range of medical information it can provide. The company has received US Food and Drug Administration approval for ...

The global artificial intelligence (AI) in drug discovery market is projected to reach USD 6.89 billion by 2029 from USD 1.86 ...

They play a central role in many aspects of metabolic diseases including obesity, diabetes, fatty liver disease, asthma and atherosclerosis. The loss-of-function genetic models of these isoforms ...

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, ...